Usefulness of the quantification of long non-coding RNA H19 in the plasma of the patients with gastric cancer

Usefulness of the quantification of long non-coding RNA H19 in the plasma of the patients with gastric cancer - Prospective observational study on long non-coding RNA H19 in gastric cancer plasma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033808

Enrollment

120

Registered

2018-08-20

Start date

2018-04-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Histologically proven gastric cancer 2) With written informed consent before surgery 3) Preoperatively diagnosed as Stage I-IV

Exclusion criteria

Exclusion criteria: patients without preoperative informed consent

Design outcomes

Primary

Measure	Time frame
Confirm whether the expression level of H19 gene increases with the progress of cancer stage	—

Secondary

Measure	Time frame
Confirm increase and decrease in expression level of H19 gene before and after surgery Compare with usefulness of tumor markers such as CEA and CA 19-9	—

Countries

Japan

Contacts

Public ContactHiroki Harada

Kitasato University School of Medicine Department of Surgery

dm16025@st.kitasato-u.ac.jp042-778-8111

Outcome results